Status and phase
Conditions
Treatments
About
The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.
Full description
The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiority framework.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Shoaib Ashraf, PhD; Sohaib Ashraf, MBBS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal